Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/12/1991 | CA2082658A1 Synthetic peptides of human papillomaviruses 1,5,6,8,11,16,18,31,33 and 56, useful in immunoassay for diagnostic purposes |
11/12/1991 | CA2082637A1 Process for producing protein |
11/12/1991 | CA2064060A1 Papillomavirus (hpv66) probe, particularly for the in vitro diagnosis of papillomavirus infections possibly accompanied with genital neoplasia, and products genetically and immunologically related to this papillomavirus |
11/12/1991 | CA2041825A1 Renin inhibitors |
11/11/1991 | WO1991017250A1 Method for the recombinant production of hiridius and hirudin-like polypeptides |
11/11/1991 | CA2063575A1 Method for the recombinant production of hirudins and hirudin-like polypeptides |
11/10/1991 | WO1991017245A1 Ubiquitin-specific protease |
11/10/1991 | WO1991016915A1 Maturation of hemopoietic cells |
11/10/1991 | CA2056359A1 Maturation of hemopoietic cells |
11/10/1991 | CA2042085A1 Process for the preparation of retrovirus immunogens and vaccines against retroviral, notably hiv, infections and obtained immunogens and vaccines |
11/09/1991 | WO1991016912A1 Metal binding proteins |
11/09/1991 | CA2081213A1 Metal binding proteins |
11/09/1991 | CA2041439A1 Muteins of the granulocyte colony stimulating factor (g-csf) |
11/09/1991 | CA2041183A1 Human and rat thymopoietin |
11/08/1991 | WO1991017173A1 Molecular recognition units |
11/08/1991 | WO1991016926A1 Vaccine compositions |
11/08/1991 | WO1991016913A1 Stabilized heparin solution |
11/08/1991 | CA2082425A1 Vaccine compositions |
11/08/1991 | CA2082272A1 Molecular recognition units |
11/08/1991 | CA2062807A1 Stabilized heparin solution |
11/07/1991 | DE4005874A1 Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine Traegergebundene recombinant proteins, methods for production and use as immunogens and vaccines |
11/06/1991 | EP0455620A2 Immunogenic protein and cDNA clone |
11/06/1991 | EP0455460A2 Tyrosine kinase negative TRKB |
11/06/1991 | EP0455424A2 Mammalian inducible promoter cascade system |
11/06/1991 | EP0455422A2 Method of treating or preventing baldness with compositions containing fibroblast growth factor |
11/06/1991 | EP0455316A2 Plasmide containing DNA sequences that bring about changes in the carbohydrate and protein concentration and the carbohydrate and protein composition in plants, and plant cells and plants containing those plasmids |
11/06/1991 | EP0455280A1 DNA fragment from lactococcus lactis and fusion proteins thereof |
11/06/1991 | EP0454898A1 Glycosaminoglycan-modified protein, process for the production of this protein, use and pharmaceutical compositions containing the same |
11/06/1991 | EP0454813A1 A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract |
11/06/1991 | EP0454767A1 Compositions and methods for treating or preventing aids, arc and hiv infection |
11/06/1991 | EP0454766A1 Polyvalent metal ion-containing antibody combining site catalysts |
11/06/1991 | EP0454765A1 Pregnancy specific proteins applications |
11/06/1991 | EP0454730A1 Somatotropin analogs |
11/06/1991 | EP0454726A1 Hindered linking agents and methods |
11/06/1991 | EP0453563A4 Diagnostic proteins to test for more than one antibody |
11/06/1991 | EP0203107B1 Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells |
11/06/1991 | CN1055952A Process for producing exogenous protein with streptomyces |
11/06/1991 | CA2041817A1 Amino acid derivatives |
11/05/1991 | WO1991017442A1 Protein-nucleic acid probes and immunoassays using same |
11/05/1991 | WO1991017246A1 Modulation of gene expression through interference with rna secondary structure |
11/05/1991 | WO1991017186A1 Beta cell antigen |
11/05/1991 | WO1991017170A1 Multimeric gelsolin fusion constructs |
11/05/1991 | WO1991016923A1 Novel synthetic grf analogs |
11/05/1991 | US5063206 Compositions having use as treatment of neuropsychiatric deficits |
11/05/1991 | US5063203 Anticoagulants, humans |
11/05/1991 | US5063158 Genetic engineering |
11/05/1991 | US5063154 Genetic engineering |
11/05/1991 | US5063150 Immunology |
11/05/1991 | US5063055 Pesticides |
11/05/1991 | US5063053 Isolation and purification of the R18 antigen of HTLV-III |
11/05/1991 | CA2082162A1 Beta cell antigen |
11/05/1991 | CA2082059A1 Synthetic grf analogs |
11/05/1991 | CA2081455A1 Protein-nucleic acid probes and immunoassays using same |
11/05/1991 | CA2063593A1 Multimeric gelsolin fusion constructs |
11/05/1991 | CA2041742A1 Stabilization of somatotropins and other proteins by modification of cysteine residues |
11/05/1991 | CA2039222A1 Preparation and isolation of single-stranded, biotinylated nucleic acids by avidin-biotin cleavage |
11/05/1991 | CA1291708C Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
11/03/1991 | WO1991017247A1 Protease deficient bacterial hosts |
11/03/1991 | CA2081342A1 Protease deficient bacterial hosts |
11/03/1991 | CA2041619A1 Mammalian inducible promoter cascade system |
11/02/1991 | CA2040099A1 Tyrosine kinase negative trkb |
10/31/1991 | WO1991017252A1 A hybrid cellular receptor |
10/31/1991 | WO1991016629A1 Ctaa 28a32, the antigen recognized by mca 28a32 |
10/31/1991 | WO1991016457A1 Cloning by complementation and related processes |
10/31/1991 | WO1991016456A1 Screening assays for compounds which inhibit the binding of c-myc to dna |
10/31/1991 | WO1991016437A1 Soluble peptide analogues containing binding sites |
10/31/1991 | WO1991016436A1 Novel protease assays |
10/31/1991 | WO1991016434A2 BACILLUS THURINGIENSIS cryIF AND cryIX GENES AND PROTEINS TOXIC TO LEPIDOPTERAN INSECTS |
10/31/1991 | WO1991016433A1 New bacillus thuringiensis strains and their genes encoding insecticidal toxins |
10/31/1991 | WO1991016430A1 NOVEL T-CELL LYMPHOMA cDNA CLONES |
10/31/1991 | WO1991016428A1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis |
10/31/1991 | WO1991016421A1 Plant thioesterases |
10/31/1991 | WO1991016420A1 Methods of preventing viral replication |
10/31/1991 | WO1991016354A1 Processes and intermediates for synthetic antibody derivatives |
10/31/1991 | WO1991016351A1 Recombinant spider silk proteins through genetic engineering |
10/31/1991 | WO1991016350A1 Aberrant, epidermal growth factor receptor dna, rna and protein forms and method |
10/31/1991 | WO1991016349A1 Expression of recombinant hemoglobin in yeast |
10/31/1991 | WO1991016344A1 Ligand-label conjugates which contain polyoxoanions of sulfur or phosphorus |
10/31/1991 | WO1991016342A1 Novel physiologically active peptide originating in hog |
10/31/1991 | WO1991016340A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase |
10/31/1991 | WO1991016339A1 Inhibitors of dipeptidyl-aminopeptidase type iv |
10/31/1991 | WO1991016335A1 Glycosylated pdgf |
10/31/1991 | WO1991016069A1 Selective cytotoxic reagents comprising toxic moieties derived from mammalian proteins |
10/31/1991 | WO1991016066A1 Composition and treatment with biologically active peptides and toxic cations |
10/31/1991 | WO1991016063A1 System for cryoprecipitating fibrinogen |
10/31/1991 | WO1991016061A1 SYNTHETIC POLY-Ig RECEPTOR, RECEPTOR-ANTIBODY COMPLEXES, PRODUCTION AND USE THEREOF |
10/31/1991 | WO1991016060A1 Method of inactivation of viral and bacterial blood contaminants |
10/31/1991 | WO1991013984A3 Interleukin-4 binding proteins |
10/31/1991 | WO1991009118A3 Activatable fibrinolytic and anti-thrombotic proteins |
10/31/1991 | CA2081771A1 Hybrid cellular receptor |
10/31/1991 | CA2081207A1 Soluble peptide analogues containing binding sites |
10/31/1991 | CA2081122A1 Plant thioesterases |
10/31/1991 | CA2081022A1 Methods of preventing viral replication |
10/31/1991 | CA2081013A1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis |
10/31/1991 | CA2080589A1 Expression of recombinant hemoglobin in yeast |
10/31/1991 | CA2080474A1 Inhibitors of dipeptidyl-aminopeptidase type iv |
10/31/1991 | CA2079601A1 Ctaa 28a32, the antigen recognized by mca 28a32 |
10/31/1991 | CA2059289A1 Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof |
10/31/1991 | CA2041454A1 Polypeptides |
10/31/1991 | CA2041395A1 Immunogenic protein and cdna clone |